Recombinant multi-species GALT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GALT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
The Alternative Names of target: GALT,Gal-1-P uridylyltransferase,Galactose-1-phosphate uridylyltransferase,Galt,UDP-glucose--hexose-1-phosphate uridylyltransferase
Go
to GALT products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP7184-Ag-1/ GM-Tg-hg-IP7184-Ag-2 | Human GALT protein | Human |
GM-Tg-rg-IP7184-Ag-1/ GM-Tg-rg-IP7184-Ag-2 | Rat GALT protein | Rat |
GM-Tg-mg-IP7184-Ag-1/ GM-Tg-mg-IP7184-Ag-2 | Mouse GALT protein | Mouse |
GM-Tg-cynog-IP7184-Ag-1/ GM-Tg-cynog-IP7184-Ag-2 | Cynomolgus/Rhesus macaque GALT protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP7184-Ag-1/ GM-Tg-felg-IP7184-Ag-2 | Feline GALT protein | Feline |
GM-Tg-cang-IP7184-Ag-1/ GM-Tg-cang-IP7184-Ag-2 | Canine GALT protein | Canine |
GM-Tg-bovg-IP7184-Ag-1/ GM-Tg-bovg-IP7184-Ag-2 | Bovine GALT protein | Bovine |
GM-Tg-equg-IP7184-Ag-1/ GM-Tg-equg-IP7184-Ag-2 | Equine GALT protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP7184-Ag-1/ GM-Tg-hg-IP7184-Ag-2;
GM-Tg-rg-IP7184-Ag-1/ GM-Tg-rg-IP7184-Ag-2;
GM-Tg-mg-IP7184-Ag-1/ GM-Tg-mg-IP7184-Ag-2; GM-Tg-cynog-IP7184-Ag-1/ GM-Tg-cynog-IP7184-Ag-2; GM-Tg-felg-IP7184-Ag-1/ GM-Tg-felg-IP7184-Ag-2; GM-Tg-cang-IP7184-Ag-1/ GM-Tg-cang-IP7184-Ag-2; GM-Tg-bovg-IP7184-Ag-1/ GM-Tg-bovg-IP7184-Ag-2; GM-Tg-equg-IP7184-Ag-1/ GM-Tg-equg-IP7184-Ag-2 |
Products Name | GALT protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | GALT |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GALT protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.